- Q3 2024 Renalytix PLC Earnings Call TranscriptMay 15, 2024£0.235 (-4.08%)Earnings
- Q1 2024 Renalytix PLC Earnings Call TranscriptNov 14, 2023£0.275 (-26.67%)Earnings
- Full Year 2023 Renalytix PLC Earnings Call TranscriptSep 28, 2023£0.575 (-25.81%)Earnings
- Q3 2023 Renalytix PLC Earnings Call TranscriptJun 09, 2023£0.825 (-5.71%)Earnings
- Half Year 2023 Renalytix PLC Earnings Call TranscriptMar 30, 2023£0.875 (+2.94%)Earnings
- Q1 2023 Renalytix PLC Earnings Call TranscriptNov 30, 2022£0.775 (+6.90%)Earnings
- Renalytix PLC at Stifel Healthcare Conference TranscriptNov 16, 2022
- Full Year 2022 Renalytix PLC Earnings Call TranscriptOct 31, 2022Earnings
- Renalytix PLC at H C Wainwright Global Investment Conference TranscriptSep 12, 2022
- Q3 2022 Renalytix PLC Earnings Call TranscriptJun 30, 2022£1.05 (-37.31%)Earnings
- Q2 2022 Renalytix PLC Earnings Call TranscriptMar 31, 2022£2.7Earnings
- Q1 2022 Renalytix PLC Earnings Call TranscriptDec 07, 2021£5.7 (-5.00%)Earnings
- Q4 2021 Renalytix PLC Earnings Call TranscriptOct 21, 2021£9.3 (+4.49%)Earnings
Q3 2023 Renalytix PLC Earnings Call Transcript
Good morning, and welcome to the Renalytix conference call to review third-quarter fiscal year 2023 financial results. (Operator Instructions) And as a reminder, this call is being recorded for replay purposes. I would now like to turn the call over to Peter DeNardo of CapComm Partners, for a few introductory comments. Sir, please go ahead.
Thank you, Chris. Thank you all for participating in today's call. Joining me today from Renalytix to provide formal remarks are James McCullough, Chief Executive Officer; Tom McLain, President; and James Sterling, Chief Financial Officer. Before we begin, I'd like to remind you that management will make statements during this call that include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.
Any statements made during this call that relate to expectations or predictions of future events, results or performance are forward-looking statements. Examples of these statements include, without limitation, the potential benefits,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)